A patient with drug‑induced urticaria was given chlorpheniramine injection, dexamethasone, hydrocortisone, and 0.1 mL epinephrine, improved for 30 minutes, but symptoms recurred despite repeat dexamethasone and chlorpheniramine; what is the next step in management?

Administer Additional Epinephrine and Prepare for Continuous Monitoring/Infusion

This patient is experiencing biphasic anaphylaxis (recurrence after initial improvement) and requires immediate repeat intramuscular epinephrine 0.3-0.5 mg in the mid-outer thigh, followed by close observation for at least 4-8 hours with preparation for epinephrine infusion if symptoms persist after 2-3 doses. 1, 2

Immediate Management

First Priority: Repeat Epinephrine

• Give IM epinephrine immediately - 0.3 mg (prepubertal) to 0.5 mg (adolescent/adult) in the vastus lateralis muscle 2, 3
• The 0.1 cc dose mentioned initially was likely inadequate (standard dosing is 0.01 mg/kg IM, maximum 0.3-0.5 mg) 2
• Epinephrine can be repeated every 5-15 minutes as needed for persistent symptoms 1, 4
• Do not delay - this is the only medication proven to prevent fatal outcomes in anaphylaxis 1, 2

Why Antihistamines and Steroids Failed

The patient's recurrence despite repeat dexamethasone and pheniramine (chlorpheniramine) demonstrates a critical principle: antihistamines and corticosteroids are completely ineffective as primary treatment for anaphylaxis 1. Here's why:

• Antihistamines have onset of 30-120 minutes and only address histamine-mediated symptoms (pruritus, urticaria), not cardiovascular collapse or bronchospasm 1
• Corticosteroids work through gene transcription changes taking hours to days - they have no role in acute anaphylaxis management 1
• Both lack the vasoconstrictor, bronchodilator, inotropic, and mast cell stabilization properties of epinephrine 1

Escalation Protocol for Persistent/Recurrent Symptoms

After Second Epinephrine Dose (if symptoms persist):

1. Continue IM epinephrine every 5 minutes 4
2. Prepare IV epinephrine infusion - should be ready after third dose or earlier at provider discretion 4
3. Aggressive IV fluid resuscitation (avoid colloids per guidelines) 5
4. Supplemental oxygen and airway management as needed 4

Monitoring Requirements

• Observe for minimum 4-8 hours after symptom resolution 3
• Biphasic reactions (like this case) occur in up to 20% of anaphylaxis cases
• Patient must be warned about possible recurrence and instructed to return immediately if symptoms reappear 3

Critical Pitfalls to Avoid

What NOT to Do:

• Do not give more steroids or antihistamines as primary treatment - they will not prevent progression 1
• Do not inject epinephrine into buttock (risk of gas gangrene), deltoid (poor absorption), or digits 3
• Do not use the same injection site repeatedly (causes tissue necrosis) 3
• Do not discharge early - biphasic reactions can occur hours later 3

Rare Consideration:

While extremely uncommon, consider that the patient could have hypersensitivity to the antihistamines or corticosteroids themselves 6, 7. If urticaria worsens specifically after these medications (not just recurs), this paradoxical reaction has been reported with both drug classes 6, 7. However, given the 30-minute improvement followed by recurrence, this is more consistent with biphasic anaphylaxis than drug-induced urticaria.

Disposition and Follow-up

• Admit for observation if required more than 2 doses of epinephrine or has persistent symptoms
• Prescribe epinephrine auto-injector for discharge 2
• Refer to Allergy/Immunology to identify trigger and provide long-term management plan
• Document exact timeline and all medications given for allergy evaluation

The key error in this case was relying on adjunctive medications (steroids/antihistamines) rather than repeating the only effective treatment: epinephrine. 1, 2